Press releases

Read more:

Categories

Archive per year

Nanologica’s Interim Report Jan – Jun 2022

FINANCIAL SUMMARY Net sales for the quarter amounted to TSEK 210 (4,497) and for the half-year to TSEK 479 (10,119) The operating result for the quarter amounted to TSEK -12,397 (-8,094) and for the half-year to TSEK -27,989 (-14,862) Result after tax for the quarter amounted to TSEK -13,473 (-9,216) and for the half-year to TSEK -29,388 (-17,061) Earnings per share before and after dilution were SEK -0.48 (-0.33) for the quarter and SEK -1.04

Read more »

Nanologica Takes Order from Insulin Manufacturer for Production

Nanologica AB (publ) has taken an order for the company’s silica for preparative chromatography for evaluation in production scale, from one of the world’s largest manufacturers of insulin. If the products meet the customer’s expectations, Nanologica expects commercial deliveries within a year. Nanologica has been working with customers within preparative chromatography since 2016 and several customers have successfully evaluated the company’s silica for preparative chromatography, NLAB Saga®, in various stages. Nanologica has been collaborating with

Read more »

Nanologica Expands Management Team for Increased Focus on Chromatography

Nanologica AB (publ) has expanded its management team with Katarina Alenäs, SVP Chromatography, as part of intensifying the company’s efforts within preparative chromatography. Katarina Alenäs took up her position as SVP Chromatograhy at Nanologica in the beginning of March, and most recently came from a role as Business Team Manager Sweden and Finland, Country General Manager Sweden and chairman of the board of Agilent Technologies Sweden AB. Katarina has a solid background and a strong

Read more »

Nanologica takes out loan of MSEK 20 within agreed credit facility

Nanologica AB (publ) has taken out a loan of MSEK 20 from the credit facility agreed in January with Flerie Invest AB. The loan is taken out to cover the company’s temporary financial needs pending expected cash flows from the operations in preparative chromatography. After this loan, the credit facility has been used in full. Parts of the proceeds will be used to repay a loan from a private financier of MSEK 10 that expires

Read more »

Bulletin from the Annual General Meeting of Nanologica AB (publ)

Today June 2nd, 2022, Nanologica AB (publ) held its annual general meeting for the financial year 2021, where the following resolutions were passed. Adoption of income statement and balance sheet for the financial year 2021 and disposition of result The annual general meeting adopted the income statement and balance sheet for the company and for the group in accordance with the presented accounting documents, and resolved, in accordance with the board’s proposal, that the accumulated

Read more »

Proposal for New Stock Option Program Withdrawn

The board of directors of Nanologica AB (publ) has decided to withdraw the proposal for a new stock option program for management and employees that was presented in the notice to Nanologica’s Annual General Meeting on June 2, 2022. The board of directors has decided to withdraw the proposal to await the outcome of the stock option programs that expire on July 1 this year. Depending on the outcome, a new stock option program may

Read more »